Prognostic significance of sphingosine kinase 2 expression in non-small cell lung cancer

Tumor Biology

Volumn 35, Issue 1, 2014, Pages 363-368

  Wang, Qiushi ^a   Li, Jingyuan ^a   Li, Guanghua ^a   Li, Yinghong ^a   Xu, Chunlin ^a   Li, Ming ^a   Xu, Guangquan ^a   Fu, Songbin ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Bio pharmaceutical Key Laboratory of Heilongjiang Province   (China)

Author keywords

Biomarker; Non small cell lung cancer (NSCLC); Proliferating cell nuclear antigen (PCNA); Sphingosine kinase 2 (SphK2)

Indexed keywords

BIOLOGICAL MARKER; CYCLINE; SPHINGOSINE KINASE 2;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG BIOPSY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RISK FACTORS; TUMOR BURDEN;

EID: 84894440020     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1051-1     Document Type: Article

References (28)

1. American Cancer Society. Cancer facts & figures 2012. Atlanta: American Cancer Society; 2012.
2. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami- Porta R, et al. The IASLC lung cancer staging project: proposals for the revision of the TNMstage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007;2:706-14.
3. Ogretmen B, HannunYA. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer. 2004;4:604-16.
4. Shida D, Takabe K, Kapitonov D, Milstien S, Spiegel S. Targeting SphK1 as a new strategy against cancer. Curr Drug Targets. 2008;9:662-73.
5. Igarashi N, Okada T, Hayashi S, Fujita T, Jahangeer S, Nakamura SI. Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis. J Biol Chem. 2003;278:46832-9.
6. Liu H, Toman RE, Goparaju S, Maceyka M, Nava VE, Sankala H, et al. Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis. J Biol Chem. 2003;278:40330-6.
7. Van Brocklyn JR, Jackson CA, PearlDK, KoturMS, Snyder PJ, Prior TWJ. Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J Neuropathol Exp Neurol. 2005;64:695-705.
8. Sankala HM, Hait NC, Paugh SW, Shida D, Lepine S, Elmore LW, et al. Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin. Cancer Res. 2007;67:10466-74.
9. Hait NC, Sarkar S, Le Stunff H, Mikami A, MaceykaM, Milstien S, et al. Role of sphingosine kinase 2 in cell migration toward epidermal growth factor. J Biol Chem. 2005;280:29462-9.
10. Wu J, Zhou J,Yao L, Lang Y, Liang Y, Chen L, et al. High expression of M3 muscarinic acetylcholine receptor is a novel biomarker of poor prognostic in patients with non-small cell lung cancer. Tumor Biol. 2013. doi:10.1007/s13277- 013-0982-x.
11. Kuwabara K, Matsuda S, Fushimi K, et al. Differences in practice patterns and costs between small cell and non-small cell lung cancer patients in Japan. Tohoku J Exp Med. 2009;217:29-35.
12. Cuvillier O, Pirianov G, Kleuser B, et al. Suppression of ceramidemediated programmed cell death by sphingosine-1-phosphate. Nature. 1996;381:800-3.
13. Mandala SM, Thornton R, Tu Z, et al. Sphingoid base 1-phosphate phosphatase: a key regulator of sphingolipid metabolism and stress response. Proc Natl Acad Sci U S A. 1998;95:150-5.
14. Olivera A, Kohama T, Edsall L, et al. Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J Cell Biol. 1999;147:545-58.
15. Kawamori T, Kaneshiro T, Okumura M, et al. Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J. 2009;23:405-14.
16. Li J, Guan HY, Gong LY, et al. Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival. Clin Cancer Res. 2008;14:6996-7003.
17. Heffernan-Stroud LA, Obeid LM. Sphingosine kinase 1 in cancer. Adv Cancer Res. 2013;117:201-35.
18. Park HW, Song JY, Kim KS, et al. Enhancement of radiosensitivity by combined ceramide and dimethylsphingosine treatment in lung cancer cells. Exp Mol Med. 2004;36:411-9.
19. Ruckhäberle E, Rody A, Engels K, Gaetje R, von Minckwitz G, Schiffmann S, et al. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res Treat. 2007;112:41-52.
20. Facchinetti MM, Gandini NA, FermentoME, et al. The expression of sphingosine kinase-1 in head and neck carcinoma. Cells Tissues Organs. 2010;192:314-24.
21. Miller AV, Alvarez SE, Spiegel S, Lebman DA. Sphingosine kinases and sphingosine-1-phosphate are critical for transforming growth factor beta-induced extracellular signal-regulated kinase 1 and 2 activation and promotion of migration and invasion of esophageal cancer cells. Mol Cell Biol. 2008;28:4142-51.
22. Cai J, Wu Y, Li C, Feng M, Shi Q, Li R, et al. Panax ginseng polysaccharide suppresses metastasis via modulating Twist expression in gastric cancer. Int J Biol Macromol. 2013;57:22-5.
23. Li C, Cai J, Geng J, Li Y,Wang Z, Li R. Purification, characterization and anticancer activity of a polysaccharide from Panax ginseng. Int J Biol Macromol. 2012;51:968-73.
24. Wu J, Zhou J, Lang Y, Yao L, Xu H, Shi H, et al. A polysaccharide from Armillaria mellea exhibits strong in vitro anticancer activity via apoptosis-involved mechanisms. Int J Biol Macromol. 2012;51:663-7.
25. Wenjing Z, Bo H, Yun S, Zhenyu W, Xiuhua Y. Immunoregulatory effects of a glucogalactan from the root of Panax quinquefolium L. Carbohydr Polym. 2012;87:2725-9.
26. Kramer-Marek G, Capala J. The role of nuclear medicine in modern therapy of cancer. Tumor Biol. 2012;33:629-40.
27. French KJ, Zhuang Y, Maines LW, Gao P, Wang W, Beljanski V, et al. Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2. J Pharmacol Exp Ther. 2010;333:129-39.
28. Gao P, Smith CD. Ablation of sphingosine kinase-2 inhibits tumor cell proliferation and migration. Mol Cancer Res. 2011;9:1509-19.